BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26705843)

  • 1. Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury.
    Kumar RG; Rubin JE; Berger RP; Kochanek PM; Wagner AK
    Brain Behav Immun; 2016 Mar; 53():183-193. PubMed ID: 26705843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.
    Santarsieri M; Kumar RG; Kochanek PM; Berga S; Wagner AK
    Brain Behav Immun; 2015 Mar; 45():15-27. PubMed ID: 25218898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury.
    Nwachuku EL; Puccio AM; Adeboye A; Chang YF; Kim J; Okonkwo DO
    Clin Neurol Neurosurg; 2016 Oct; 149():1-5. PubMed ID: 27450760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury.
    Santarsieri M; Niyonkuru C; McCullough EH; Dobos JA; Dixon CE; Berga SL; Wagner AK
    J Neurotrauma; 2014 Apr; 31(8):699-712. PubMed ID: 24354775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome.
    Kumar RG; Diamond ML; Boles JA; Berger RP; Tisherman SA; Kochanek PM; Wagner AK
    Brain Behav Immun; 2015 Mar; 45():253-62. PubMed ID: 25555531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
    Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S
    Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mathematical model of neuroinflammation in severe clinical traumatic brain injury.
    Vaughan LE; Ranganathan PR; Kumar RG; Wagner AK; Rubin JE
    J Neuroinflammation; 2018 Dec; 15(1):345. PubMed ID: 30563537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treelet transform analysis to identify clusters of systemic inflammatory variance in a population with moderate-to-severe traumatic brain injury.
    Vijapur SM; Vaughan LE; Awan N; DiSanto D; McKernan GP; Wagner AK
    Brain Behav Immun; 2021 Jul; 95():45-60. PubMed ID: 33524553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of a Combination of Circulating Biomarkers in Critically Ill Patients with Traumatic Brain Injury: Results from the European CREACTIVE Study.
    Gradisek P; Carrara G; Antiga L; Bottazzi B; Chieregato A; Csomos A; Fainardi E; Filekovic S; Fleming J; Hadjisavvas A; Kaps R; Kyprianou T; Latini R; Lazar I; Masson S; Mikaszewska-Sokolewicz M; Novelli D; Paci G; Xirouchaki N; Zanier E; Nattino G; Bertolini G;
    J Neurotrauma; 2021 Oct; 38(19):2667-2676. PubMed ID: 34235978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Profiles of P-Tau, T-Tau, and P-Tau:Tau Ratios in Cerebrospinal Fluid and Blood from Moderate-Severe Traumatic Brain Injury Patients and Relationship to 6-12 Month Global Outcomes.
    Rubenstein R; McQuillan L; Wang KKW; Robertson C; Chang B; Yang Z; Xu H; Williamson J; Wagner AK
    J Neurotrauma; 2024 Feb; 41(3-4):369-392. PubMed ID: 37725589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury.
    Goyal A; Failla MD; Niyonkuru C; Amin K; Fabio A; Berger RP; Wagner AK
    J Neurotrauma; 2013 Jun; 30(11):946-57. PubMed ID: 23190274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMPACT probability of poor outcome and plasma cytokine concentrations are associated with multiple organ dysfunction syndrome following traumatic brain injury.
    Lee S; Hwang H; Yamal JM; Goodman JC; Aisiku IP; Gopinath S; Robertson CS
    J Neurosurg; 2019 Jan; 131(6):1931-1937. PubMed ID: 30641838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study.
    Lindblad C; Pin E; Just D; Al Nimer F; Nilsson P; Bellander BM; Svensson M; Piehl F; Thelin EP
    Crit Care; 2021 Mar; 25(1):103. PubMed ID: 33712077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-Derived Neurotrophic Factor (BDNF) in Traumatic Brain Injury-Related Mortality: Interrelationships Between Genetics and Acute Systemic and Central Nervous System BDNF Profiles.
    Failla MD; Conley YP; Wagner AK
    Neurorehabil Neural Repair; 2016 Jan; 30(1):83-93. PubMed ID: 25979196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?
    Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B
    J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated cerebrospinal fluid concentrations of N-acetylaspartate correlate with poor outcome in a pilot study of severe brain trauma.
    Osier ND; Ziari M; Puccio AM; Poloyac S; Okonkwo DO; Minnigh MB; Beers SR; Conley YP
    Brain Inj; 2019; 33(10):1364-1371. PubMed ID: 31305157
    [No Abstract]   [Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Inflammation After Severe Traumatic Brain Injury: Characterization and Associations With Outcome at 6 and 12 Months Postinjury.
    Kumar RG; Boles JA; Wagner AK
    J Head Trauma Rehabil; 2015; 30(6):369-81. PubMed ID: 24901329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome.
    Pérez-Bárcena J; Crespí C; Frontera G; Llompart-Pou JA; Salazar O; Goliney V; Ibáñez J; Bullock MR; de Rivero Vaccari JP
    J Neurosurg; 2020 May; 134(5):1644-1649. PubMed ID: 32357337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.